Obstructive sleep apnea-hypopnea syndrome is a severe and potentially fatal sleep-related breathing disorder characterized by recurrent episodes of apnea and hypopnea during sleep, caused by narrowing or obstruction of the upper airway due to various factors.
Conditions
Interventions
Data of all polysomnography (PSG) cases in the sleep apnea center of this hospital:None
Sponsors
Peking University Shenzhen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. People who have visited the sleep center of our hospital and undergone PSG examinations; 2. Age >=18 years old; 3. Complete cognition; 4. Have typical snoring symptoms; 5. Complete baseline data (including PSG/ physical measurements/questionnaires); 6. Past medical record data that may involve special groups (employees of research institutions or sponsors) and vulnerable groups (pregnant women, people with low educational levels) should be included in cases where all other data are complete
Exclusion criteria
Exclusion criteria: Exclude those who have received OSAHS treatment, those with combined maxillofacial deformities or acute severe diseases, those with central sleep apnea, and those with missing medical record data of more than 20%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Model evaluation index;Clinical indicators (including PSG diagnosis results, sex, age, BMI >= 28 kg/m^2, neck-to-waist ratio);Symptom characteristics (including snoring severity, Epworth Sleepiness Scale [ESS], morning dry mouth, self-reported breathlessness);Comorbidity information (including hypothyroidism, acromegaly, heart failure, stroke, gastroesophageal reflux, neuromuscular disorders, family history of OSAHS, etc.);Behavioral factors (including long-term smoking (>=10 cigarettes/day × 5 years), heavy alcohol consumption (ethanol intake >=40 g/day × 5 years), use of sedative/hypnotic or muscle relaxant medications);Anatomical factors (including nasal obstruction, grade II or higher tonsillar hypertrophy, soft palate laxity, elongated or thickened uvula, pharyngeal narrowing, pharyngeal tumors, pharyngeal mucosal hypertrophy, macroglossia, posterior displacement of the tongue base, mandibular retrognathia, and micrognathia, etc.); | — |
Countries
China
Contacts
Public ContactLiu Shuang
Peking University Shenzhen Hospital
Outcome results
None listed